Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2008NeoplasiaOpen Access

Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells Is a Primary Target for Therapy with Tyrosine Kinase Inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

TKToshio KuwaiAmerican Society for Gastrointestinal EndoscopyTNToru NakamuraTSTakamitsu SasakiPanasonic (Japan)

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kuwai et al. (2008) studied this question.

synapsesocial.com/papers/6a7df42933dcb27c99cb62d9https://doi.org/10.1593/neo.08200
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry2005 · 1,085 citations
  2. 2A Novel Mechanism of Resistance to Epidermal Growth Factor Receptor Antagonism In vivo2007 · 50 citations
  3. 3Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells in Human Renal Cell Carcinoma Is a Primary Target for Therapy by Tyrosine Kinase Inhibitors2006 · 29 citations
  4. 4Antivascular Therapy for Orthotopic Human Ovarian Carcinoma through Blockade of the Vascular Endothelial Growth Factor and Epidermal Growth Factor Receptors2005 · 74 citations